{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1164.29","meta":{"versionId":"4","lastUpdated":"2017-06-21T01:00:04.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.29","version":"20170621","name":"Denosumab for osteoporosis treatment with non metastatic prostate cancer","status":"active","date":"2017-06-21T01:00:04-04:00","publisher":"LUGPA Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"993452","display":"1 ML denosumab 60 MG/ML Prefilled Syringe"}]}]},"expansion":{"identifier":"urn:uuid:048a2722-07a5-4800-bdd6-a0379e0b50b6","timestamp":"2022-06-10T06:52:35-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"993452","display":"1 ML denosumab 60 MG/ML Prefilled Syringe"}]}}